https://www.cs-medica.com/cs-medica-a-s-notice-of-annual-general-meeting/ 2026-03-17T15:04:03+00:00 https://www.cs-medica.com/cs-medica-a-s-interim-report-q1-october-december-2025/ 2026-01-25T13:21:22+00:00 https://www.cs-medica.com/cs-medica-offers-shareholders-the-opportunity-to-transfer-delisted-shares-before-31-december-2025/ 2025-12-18T10:11:46+00:00 https://www.cs-medica.com/cs-medica-a-s-interim-report-q2-january-march-2025/ 2025-05-17T11:59:25+00:00 https://www.cs-medica.com/cs-medica-a-s-minutes-of-the-general-assembly/ 2025-05-17T11:55:52+00:00 https://www.cs-medica.com/cs-medica-faces-tough-q1-with-strategic-shifts/ 2025-05-17T11:52:46+00:00 https://www.cs-medica.com/ceo-letter-a-moment-of-transition-for-cs-medica/ 2025-02-18T10:21:08+00:00 https://www.cs-medica.com/cs-medica-a-s-announces-comprehensive-changes-in-board-and-management-to-navigate-current-challenges-and-drive-future-growth/ 2025-02-18T10:20:38+00:00 https://www.cs-medica.com/cs-medica-a-s-notice-of-shareholders-annual-general-meeting-2/ 2025-02-18T10:15:57+00:00 https://www.cs-medica.com/cs-medica-achieves-fourth-european-patent-with-cannasen-psoriasis-gel/ 2025-01-10T16:06:43+00:00 https://www.cs-medica.com/wp-content/uploads/2019/05/Psoriasis-Gel-web.png https://www.cs-medica.com/cs-medica-closes-1-1-mdkk-white-label-cbd-infused-product-order-for-italy/ 2025-01-06T10:37:54+00:00 https://www.cs-medica.com/update-from-chairperson-delisting-of-cs-medica-a-s-from-spotlight-stock-market/ 2025-01-02T08:48:43+00:00 https://www.cs-medica.com/cs-medica-explores-listing-and-strategic-options-to-protect-shareholder-company-value/ 2024-12-25T09:52:32+00:00 https://www.cs-medica.com/cs-medica-responds-to-spotlight-stock-markets-delisting-notification/ 2024-12-20T14:01:22+00:00 https://www.cs-medica.com/cs-medicas-subsidiary-cannordic-marks-milestone-with-first-invoice-to-iraq/ 2024-12-19T11:08:01+00:00 https://www.cs-medica.com/update-on-the-share-distribution-of-cannordic-shares/ 2024-11-27T10:34:11+00:00 https://www.cs-medica.com/cs-medica-welcomes-the-danish-governments-proposal-to-make-the-pilot-program-for-prescription-based-medicinal-cannabis-permanent/ 2024-11-27T10:31:55+00:00 https://www.cs-medica.com/cs-medica-a-s-minutes-of-extraordinary-general-meeting-3/ 2024-11-13T08:39:39+00:00 https://www.cs-medica.com/cs-medica-expands-presence-in-eastern-europe-through-new-partnership/ 2024-11-12T10:07:35+00:00 https://www.cs-medica.com/cs-medica-a-s-update-on-the-strategic-rationale-behind-cannordic-ipo-and-aim-for-capital-increase/ 2024-11-12T10:07:00+00:00 https://www.cs-medica.com/cs-medica-a-s-update-from-ceo-progress-on-cannordic-ipo-share-distribution-upcoming-market-analysis/ 2024-11-04T11:35:13+00:00 https://www.cs-medica.com/cs-medica-a-s-notice-of-extraordinary-general-meeting-3/ 2024-11-04T11:23:50+00:00 https://www.cs-medica.com/cs-medica-achieves-key-milestone-in-mdr-compliance-with-finalized-classification-solidifying-unique-market-position-for-medical-devices/ 2024-11-04T11:23:23+00:00 https://www.cs-medica.com/cs-medica-valued-at-1716-dkk-e2-30-per-share-ahead-of-german-ipo-highlighting-unique-regulatory-position-and-growth-potential/ 2024-11-04T11:18:02+00:00 https://www.cs-medica.com/cs-medica-a-s-secures-sales-approval-in-azerbaijan-georgia-valued-at-1-17-mdkk/ 2024-10-21T10:34:51+00:00 https://www.cs-medica.com/cs-medica-a-s-share-capital-increase-registered-with-the-danish-companies-registration-office/ 2024-10-21T10:30:24+00:00 https://www.cs-medica.com/cs-medicas-subsidiary-signs-agreement-to-target-the-german-market-leveraging-expertise-of-nimbus-health-a-dr-reddys-laboratories-company/ 2024-09-30T08:02:41+00:00 https://www.cs-medica.com/cs-medica-a-s-update-from-ceo-strategic-developments-on-cannordic-planned-ipo-milestones/ 2024-09-30T07:52:48+00:00 https://www.cs-medica.com/cs-medica-a-s-announces-strategic-partnership-with-scan-medpartners-to-expand-reach-into-the-us-market/ 2024-09-18T15:19:31+00:00 https://www.cs-medica.com/cs-medica-announces-approval-of-cannasen-pain-patch-in-malaysia-and-trademark-registration-in-thailand/ 2024-09-17T11:04:42+00:00 https://www.cs-medica.com/ceo-letter-updates-on-bsi-and-last-months-activities/ 2024-09-03T07:47:41+00:00 https://www.cs-medica.com/cannordic-india-ltd-a-cs-medica-subsidiary-signs-letter-of-intent-with-the-pharmaceutical-company-zuventus-healthcare-to-launch-cannasen-in-india/ 2024-09-02T09:26:48+00:00 https://www.cs-medica.com/cs-medica-achieves-mdr-classification-setting-new-standards-in-substance-based-medical-devices/ 2024-08-22T07:16:05+00:00 https://www.cs-medica.com/cs-medica-q3-2023-2024-growth-through-strategic-regulatory-and-market-adaptations/ 2024-08-20T07:35:10+00:00 https://www.cs-medica.com/cs-medica-q3-2023-2024-results-strong-revenue-growth-of-400-despite-production-delays/ 2024-08-16T12:30:48+00:00 https://www.cs-medica.com/cs-medicas-cannordic-names-pharma-avanti-as-preferred-partner-in-brazil/ 2024-08-09T09:24:43+00:00 https://www.cs-medica.com/cs-medicas-subsidiary-cannordic-signs-distributor-partnership-with-pharmalink/ 2024-08-04T07:23:49+00:00 https://www.cs-medica.com/cs-medica-a-s-minutes-of-extraordinary-general-meeting-2/ 2024-08-01T08:24:27+00:00 https://www.cs-medica.com/cs-medica-leverages-strategic-partnerships-for-cannasen-brand-launch-in-apac-and-mena/ 2024-07-26T08:03:40+00:00 https://www.cs-medica.com/cs-medica-receives-intention-to-grant-for-european-patent-application-concerning-cannasen-psoriasis-gel-reinforcing-leadership-in-cbd-infused-dermatological-innovations/ 2024-07-25T10:07:19+00:00 https://www.cs-medica.com/cs-medica-stock-now-also-traded-on-xetra/ 2024-07-25T09:59:05+00:00 https://www.cs-medica.com/cs-medica-a-s-secures-repurchase-orders-from-key-european-partners/ 2024-07-22T09:04:00+00:00 https://www.cs-medica.com/cs-medica-announces-strategic-partnerships-to-enhance-funding/ 2024-07-16T08:48:49+00:00 https://www.cs-medica.com/cs-medica-a-s-notice-of-extraordinary-general-meeting-2/ 2024-07-16T08:44:06+00:00 https://www.cs-medica.com/cs-medica-ceo-insights-on-achievements-and-future-plans/ 2024-07-01T08:33:47+00:00 https://www.cs-medica.com/cs-medica-a-s-minutes-of-extraordinary-general-meeting/ 2024-07-01T08:20:56+00:00 https://www.cs-medica.com/cs-medica-group-completes-product-registration-of-cannasen-cbd-infused-medical-devices-in-israel/ 2024-06-18T08:36:46+00:00 https://www.cs-medica.com/cs-medica-announces-strategic-partnership-with-onemed/ 2024-06-12T13:39:20+00:00 https://www.cs-medica.com/strategic-expansion-through-innovation-and-collaboration/ 2024-06-11T08:19:01+00:00 https://www.cs-medica.com/cs-medica-a-s-notice-of-extraordinary-general-meeting/ 2024-06-10T13:31:32+00:00 https://www.cs-medica.com/cs-medica-plans-stock-spin-off-and-listing-of-cannordic/ 2024-06-10T13:26:16+00:00 https://www.cs-medica.com/cs-medica-receives-2-mdkk-to-support-its-short-term-financial-obligations/ 2024-05-30T12:03:23+00:00 https://www.cs-medica.com/cs-medica-a-s-announces-financial-results-for-the-first-half-of-the-financial-year-2023-24/ 2024-05-17T15:15:12+00:00 https://www.cs-medica.com/cs-medica-a-s-enters-new-partnership-with-award-winning-otc-company-holding-a-strong-position-in-the-chronic-pain-segment-in-germany/ 2024-04-30T14:43:49+00:00 https://www.cs-medica.com/wp-content/uploads/2023/05/2021-11-pain-patch-mockup.jpg https://www.cs-medica.com/ceo-lone-henriksen-buys-shares-in-the-company-5/ 2024-04-30T14:30:32+00:00 https://www.cs-medica.com/cs-medica-advances-global-reach-with-180%cb%9a-drug-store-alliance-powered-by-pull-market-strategy/ 2024-04-22T14:43:43+00:00 https://www.cs-medica.com/replay-q4-2023-presentation-april-12th-2024/ 2024-04-18T11:30:45+00:00 https://www.cs-medica.com/cs-medica-a-s-breaks-through-asian-market-barrier-with-approval-of-protective-nasal-gel-in-malaysia/ 2024-04-15T10:04:30+00:00 https://www.cs-medica.com/wp-content/uploads/2023/10/WEB-Nasal-Protect-TubeBox-med-skygge.png https://www.cs-medica.com/annual-report-2022-2023-presentation-cs-medica/ 2024-04-04T10:36:43+00:00 https://www.cs-medica.com/cs-medica-update-rescheduled-q4-2023-presentation/ 2024-04-04T08:24:03+00:00 https://www.cs-medica.com/release-of-2023-q-report-for-the-period-october-december-2023-including-an-invitation-to-a-live-streamed-conference-call-on-5st-april-at-11-am-cet/ 2024-03-29T10:41:03+00:00 https://www.cs-medica.com/letter-from-the-ceo-cs-medicas-2024-progress-report/ 2024-02-28T15:24:40+00:00 https://www.cs-medica.com/cs-medica-a-s-partners-with-new-distributor-to-launch-cannasen-into-jordan/ 2024-02-20T09:47:39+00:00 https://www.cs-medica.com/cs-medica-a-s-publication-of-annual-report-2022-2023/ 2024-02-15T09:55:45+00:00 https://www.cs-medica.com/cs-medica-a-s-notice-of-shareholders-annual-general-meeting/ 2024-02-15T09:12:43+00:00 https://www.cs-medica.com/cs-medica-a-s-achieves-new-milestone-with-patent-on-their-wound-care-treatment/ 2024-02-02T16:05:34+00:00 https://www.cs-medica.com/wp-content/uploads/2024/02/02-02-24-Patent-Woundgel.png https://www.cs-medica.com/cs-medica-breaks-new-ground-in-australia-with-registration-of-cannasen-pain-patch-and-launch-of-its-cosmetic-products/ 2024-01-26T15:38:32+00:00 https://www.cs-medica.com/cs-medica-a-s-announces-fda-authorization-for-commercialization-for-eight-products-in-the-u-s-market/ 2023-12-27T12:44:51+00:00 https://www.cs-medica.com/replay-q4-2022-23-presentation/ 2023-12-14T13:38:26+00:00 https://www.cs-medica.com/cs-medica-a-s-presents-the-ceo-letter-of-december-2023/ 2023-12-14T13:35:25+00:00 https://www.cs-medica.com/wp-content/uploads/2023/12/foto1_1200px.png https://www.cs-medica.com/wp-content/uploads/2023/12/foto2_1200px.png https://www.cs-medica.com/wp-content/uploads/2023/12/foto4_1200px.png https://www.cs-medica.com/wp-content/uploads/2023/12/foto3_1200px.png https://www.cs-medica.com/cs-medica-postpones-its-annual-report-to-february-24-2024-and-the-annual-general-meeting-to-february-29-2024/ 2023-12-14T13:29:17+00:00 https://www.cs-medica.com/release-of-2022-2023-q4-report-for-the-period-july-september-2023-including-an-invitation-to-a-live-streamed-conference-call-on-5st-december-at-11-am-cet/ 2023-11-29T12:46:50+00:00 https://www.cs-medica.com/cs-medica-a-s-achieves-milestone-with-patent-on-nasal-protect-gel/ 2023-10-31T11:29:51+00:00 https://www.cs-medica.com/wp-content/uploads/2023/10/nasal-protect-and-patent.png https://www.cs-medica.com/cannasen-is-now-a-registered-brand-in-australia/ 2023-10-27T12:21:59+00:00 https://www.cs-medica.com/danske-bank-backs-cs-medica-with-dkk-12-million-credit-line/ 2023-10-18T11:02:32+00:00 https://www.cs-medica.com/cs-medica-named-finalist-in-the-2023-european-lifestars-awards-for-post-ipo-raise-of-the-year/ 2023-10-18T11:01:42+00:00 https://www.cs-medica.com/cs-medica-announces-indian-states-fda-approval-for-two-cosmetic-products/ 2023-10-18T10:59:49+00:00 https://www.cs-medica.com/wp-content/uploads/2023/10/hairlos-skin-relief.jpg https://www.cs-medica.com/cs-medica-initiates-registration-of-6-medical-devices-in-malaysia-through-their-joint-venture-rongshi-medica-co-ltd/ 2023-09-18T10:27:41+00:00 https://www.cs-medica.com/cs-medicas-joint-venture-with-rongshi-successfully-represented-at-cphi-pmec-china-2023/ 2023-09-06T09:32:21+00:00 https://www.cs-medica.com/cs-medica-a-s-achieves-milestone-with-patent-on-nasal-night-spray/ 2023-08-30T11:57:44+00:00 https://www.cs-medica.com/wp-content/uploads/2023/08/1-patent-nasal-night.png https://www.cs-medica.com/wp-content/uploads/2019/05/Nasal-Night-Spray_MD.jpg https://www.cs-medica.com/release-of-2022-2023-q3-report-for-the-period-april-june-2023-including-an-invitation-to-a-live-streamed-conference-call-on-8nd-august-at-10-am-cet/ 2023-07-25T08:51:51+00:00 https://www.cs-medica.com/cannordic-india-pvt-ltd-is-established-to-expand-presence-in-india/ 2023-07-16T07:36:44+00:00 https://www.cs-medica.com/statement-of-extraordinary-general-meeting-3/ 2023-07-03T08:37:47+00:00 https://www.cs-medica.com/cs-medica-a-s-secures-trademark-approval-in-canada/ 2023-06-16T16:10:04+00:00 https://www.cs-medica.com/notice-of-extraordinary-general-meeting-2/ 2023-06-15T13:57:51+00:00 https://www.cs-medica.com/cs-medica-a-s-secures-future-compliance-with-new-medical-device-regulation-through-signed-contract-with-notify-body/ 2023-06-15T13:57:16+00:00 https://www.cs-medica.com/cs-medica-onboards-distributors-with-first-year-orders-of-dkk-5-6m-and-cash-flow-positively-effect-by-shorter-lead-times/ 2023-05-26T09:45:52+00:00 https://www.cs-medica.com/replay-conference-call-24th-may-2023-q2-report/ 2023-05-25T12:21:08+00:00 https://www.cs-medica.com/publication-of-q2-2022-2023-report-invitation-to-live-streamed-conference-on-may-24-at-10-am-cet/ 2023-05-17T07:48:43+00:00 https://www.cs-medica.com/cannasen-pain-patch-receives-approval-from-israels-ministry-of-health-and-is-set-to-debut-as-the-first-ever-otc-product-with-cbd-in-israel/ 2023-05-15T09:50:31+00:00 https://www.cs-medica.com/wp-content/uploads/2023/05/2021-11-pain-patch-mockup.jpg https://www.cs-medica.com/cs-medica-a-s-exhibits-at-the-leading-event-vitafoods-europe-with-suppliers-and-experts-from-over-100-countries-today/ 2023-05-09T12:58:33+00:00 https://www.cs-medica.com/cs-medica-announces-positive-results-from-clinical-trial-of-nasal-protect-gel-for-hay-fever-allergic-rhinitis/ 2023-05-08T13:10:25+00:00 https://www.cs-medica.com/cs-medica-joint-venture-rongshi-medica-ordos-co-ltd-update/ 2023-04-27T15:05:44+00:00 https://www.cs-medica.com/cs-medica-greenlights-establishment-of-cannordic-india-pvt-ltd-as-part-of-global-expansion-strategy/ 2023-04-16T09:43:03+00:00 https://www.cs-medica.com/statement-of-extraordinary-general-meeting-2/ 2023-04-14T14:39:41+00:00 https://www.cs-medica.com/cs-medica-a-s-announces-proof-of-concept-with-successful-clinical-trial-results-of-cannasen-pain-patch/ 2023-04-14T13:53:44+00:00 https://www.cs-medica.com/medical-device-company-approved-to-prolong-mdr-transition-until-31-december-2028/ 2023-03-30T16:46:45+00:00 https://www.cs-medica.com/notice-of-extraordinary-general-meeting/ 2023-03-30T08:59:57+00:00 https://www.cs-medica.com/cs-medica-has-entered-a-joint-venture-regarding-production-of-cs-medicas-cannasen-cbd-medical-products-in-china-and-distribution-of-cannasen-cbd-products-to-the-asian-market/ 2023-03-26T18:12:01+00:00 https://www.cs-medica.com/cs-medica-has-entered-into-agreement-with-investor-regarding-directed-share-issue-of-dkk-60m-at-dkk-28-13-per-share/ 2023-03-26T18:02:59+00:00 https://www.cs-medica.com/aktieinfo-has-published-an-equity-research-report-on-cs-medica/ 2023-03-03T12:15:23+00:00 https://www.cs-medica.com/ceo-lone-henriksen-cfo-gitte-lund-henriksen-and-coo-heidi-ahlefeldt-laurvig-buys-shares-in-the-company/ 2023-03-01T16:13:47+00:00 https://www.cs-medica.com/minutes-of-the-general-assembly/ 2023-02-25T14:26:00+00:00 https://www.cs-medica.com/release-of-2022-2023-q1-report/ 2023-02-17T08:52:05+00:00 https://www.cs-medica.com/cs-medica-engages-a-financial-advisor/ 2023-02-13T14:17:02+00:00 https://www.cs-medica.com/cs-medica-a-s-issues-additional-information-to-the-press-release-that-was-sent-out-at-1652-cet-january-18-2022-the-additional-information-relates-to-the-terms-of-the-loan/ 2023-02-03T11:58:30+00:00 https://www.cs-medica.com/notice-of-shareholders-annual-general-meeting/ 2023-01-31T09:29:32+00:00 https://www.cs-medica.com/publication-of-annual-report-2021-2022/ 2023-01-31T09:23:17+00:00 https://www.cs-medica.com/live-streamed-session-following-the-release-of-the-annual-report-2021-2022-is-postponed-to-wednesday-1st-of-february-at-1500-1530-cest/ 2023-01-30T11:03:18+00:00 https://www.cs-medica.com/postponement-of-annual-general-meeting/ 2023-01-27T13:24:21+00:00 https://www.cs-medica.com/cs-medicas-products-available-on-amazon-se/ 2023-01-25T14:35:13+00:00 https://www.cs-medica.com/cannordic-a-s-and-cannasen-cbd-has-been-chosen-to-participate-in-the-vitafoods-europe-2022-innovation-tours/ 2023-01-25T14:32:40+00:00 https://www.cs-medica.com/cs-medica-reports-the-very-successful-results-from-the-final-clinical-trial-on-nga-01cannasencbd-arthritis-gel-against-placebo/ 2023-01-25T14:31:43+00:00 https://www.cs-medica.com/wp-content/uploads/2021/09/gigt-gel-news.png https://www.cs-medica.com/cannansencbd-anti-hair-loss-serum-has-been-successfully-approved-in-the-united-arab-emirates/ 2023-01-25T14:29:32+00:00 https://www.cs-medica.com/wp-content/uploads/2022/02/anti-hairloss-link.jpg https://www.cs-medica.com/cs-medica-a-s-invites-to-a-live-streamed-session-of-the-annual-report-2021-2022-on-january-30th-at-1500-1530/ 2023-01-20T16:08:28+00:00 https://www.cs-medica.com/cs-medica-and-rongshi-fail-to-reach-a-signed-agreement-and-terminates-negotiations-the-negotiation-with-heilongjiang-fuyu-shengkun-textile-industry-co-is-closed-conjointly/ 2023-01-20T12:40:56+00:00 https://www.cs-medica.com/update-on-cbd-activity-research-and-future-patent/ 2023-01-02T14:21:22+00:00 https://www.cs-medica.com/ceo-letter-of-december-2022/ 2023-01-02T09:49:47+00:00 https://www.cs-medica.com/update-on-clinical-trials/ 2022-12-28T15:45:57+00:00 https://www.cs-medica.com/cs-medica-a-s-the-proposal-to-extend-the-transition-period-under-the-medical-devices-regulation-eu-2017-745-mdr-is-good-news-for-the-company/ 2022-12-20T08:57:04+00:00 https://www.cs-medica.com/cs-medica-signs-deal-with-a-new-distributor-for-the-united-kingdom-and-sweden/ 2022-12-20T08:55:07+00:00 https://www.cs-medica.com/cs-medica-a-s-publication-of-interim-report-q4-year-end-report/ 2022-11-18T08:09:16+00:00 https://www.cs-medica.com/cs-medica-a-s-invites-to-a-live-streamed-session-of-the-q4-2021-2022-report-on-november-18th-at-1100-1130-cest/ 2022-11-17T09:13:53+00:00 https://www.cs-medica.com/cs-medica-presents-ceo-letter-of-october-2022/ 2022-10-31T12:17:06+00:00 https://www.cs-medica.com/cs-medica-a-s-board-member-resignation/ 2022-10-26T08:06:51+00:00 https://www.cs-medica.com/cs-medica-closes-the-year-with-new-strong-partners/ 2022-10-10T14:37:01+00:00 https://www.cs-medica.com/cs-medica-a-s-signs-second-loi-with-investor-about-a-directed-issue-of-60-mdkk-shares-at-a-share-price-of-dkk-3150-per-share/ 2022-10-02T16:14:04+00:00 https://www.cs-medica.com/cs-medica-receives-order-for-balkan-countries/ 2022-09-29T13:20:37+00:00 https://www.cs-medica.com/cs-medica-intensifies-its-presence-on-amazon-platforms/ 2022-09-27T14:12:54+00:00 https://www.cs-medica.com/cs-medica-presents-ceo-letter-of-september-2022/ 2022-09-26T07:42:14+00:00 https://www.cs-medica.com/cs-medica-provides-patent-update-2/ 2022-09-22T10:02:22+00:00 https://www.cs-medica.com/cs-medica-a-s-prepare-for-listing-on-nasdaq-main-market-in-denmark/ 2022-09-20T07:52:43+00:00 https://www.cs-medica.com/cs-medica-receives-order-from-alsitan-germany-alsitan-expands-their-product-portfolio/ 2022-09-16T16:05:38+00:00 https://www.cs-medica.com/cs-medica-a-s-warrant-exercise-registered-with-the-danish-companies-registration-office/ 2022-09-08T08:48:06+00:00 https://www.cs-medica.com/cs-medica-announces-that-their-6-cannansencbd-medical-products-has-been-successfully-registered-at-mhra-for-sales-in-united-kingdom/ 2022-09-07T10:35:32+00:00 https://www.cs-medica.com/cs-medica-a-s-raises-approx-dkk-9-9-million-through-warrant-exercise/ 2022-09-06T08:28:47+00:00 https://www.cs-medica.com/cs-medica-reports-proof-of-concept-in-the-results-from-the-clinical-trial-on-ngp-01-cannasencbd-psoriasis-gel-against-placebo/ 2022-08-29T06:57:38+00:00 https://www.cs-medica.com/cs-medica-a-s-change-date-for-live-streamed-qa-event-to-august-29th-at-1000-1100-cet/ 2022-08-28T14:09:21+00:00 https://www.cs-medica.com/cs-medica-a-s-invites-to-a-live-streamed-qa-event-on-september-2nd-at-1400-1430-cest/ 2022-08-26T13:30:56+00:00 https://www.cs-medica.com/last-day-of-trading-in-warrants-of-series-to-1-is-30-august-2022/ 2022-08-26T08:18:43+00:00 https://www.cs-medica.com/cs-medica-a-s-signs-loi-with-investor-about-a-directed-issue-of-60-mdkk-at-a-share-price-of-dkk-3150-per-share/ 2022-08-25T16:16:12+00:00 https://www.cs-medica.com/wp-content/uploads/2022/08/22-08-25_LOI.jpg https://www.cs-medica.com/cs-medica-signs-agreements-with-two-out-of-the-three-leading-danish-pharmacy-chains/ 2022-08-24T07:26:37+00:00 https://www.cs-medica.com/wp-content/uploads/2022/08/2022-08-23-apotek_intro-1200px_1.jpg https://www.cs-medica.com/cs-medica-to2-incentive-warrants-issued-to-diaz-capital-invest-ab-is-exercised-with-255300-shares/ 2022-08-24T07:08:12+00:00 https://www.cs-medica.com/cs-medica-received-the-first-order-valued-dkk-2-6-million-for-the-israeli-market/ 2022-08-23T15:05:32+00:00 https://www.cs-medica.com/wp-content/uploads/2022/08/israel-forbe-cannasen-730x411-1.png https://www.cs-medica.com/cs-medica-has-extended-the-cooperation-with-their-partner-nutrin-manufacturer-and-rd-partner-on-distributing-nutrins-developed-lozenges-protecting-against-covid-19-infection/ 2022-08-22T13:32:33+00:00 https://www.cs-medica.com/based-on-a-dialog-with-a-european-based-veterinarian-company-cs-medicas-vet-product-line-is-pulled-forward-engaging-a-targeted-marked-of-us1-billion-yearly/ 2022-08-20T14:56:27+00:00 https://www.cs-medica.com/cs-medica-intensifies-their-discussion-with-potential-investors-regarding-a-direct-issue-on-a-share-price-goal-of-3150-dkk/ 2022-08-18T15:57:54+00:00 https://www.cs-medica.com/the-exercise-period-for-warrants-of-series-to-1-begins-today/ 2022-08-18T13:33:29+00:00 https://www.cs-medica.com/cfo-gitte-lund-henriksen-buys-more-shares-in-the-company-3/ 2022-08-18T12:39:18+00:00 https://www.cs-medica.com/cco-mikkel-raahauge-nielsen-buys-shares-in-the-company/ 2022-08-17T17:49:25+00:00 https://www.cs-medica.com/groundbreaking-discovery-in-the-natural-cannabinoid-cbds-activity-in-the-body/ 2022-08-15T14:25:10+00:00 https://www.cs-medica.com/cs-medica-a-s-invites-to-a-live-streamed-status-event-on-august-16-at-1600-cest/ 2022-08-15T14:20:03+00:00 https://www.cs-medica.com/ceo-lone-henriksen-buys-shares-in-the-company-4/ 2022-08-14T17:09:01+00:00 https://www.cs-medica.com/publication-of-interim-report-q3-2021-2022/ 2022-08-12T08:33:10+00:00 https://www.cs-medica.com/cs-medica-brings-forward-publication-of-interim-report-for-q3/ 2022-08-12T08:16:48+00:00 https://www.cs-medica.com/cs-medica-announces-voluntarily-extension-of-lock-up-agreement-for-ceo-and-cfo/ 2022-08-05T10:08:59+00:00 https://www.cs-medica.com/cannasen-is-now-a-registered-brand-in-hong-kong-and-new-zeeland/ 2022-07-26T15:20:37+00:00 https://www.cs-medica.com/ceo-lone-henriksen-buys-shares-in-the-company-3/ 2022-07-14T13:44:53+00:00 https://www.cs-medica.com/positive-clinical-trial-results-from-the-final-report-on-nga-01-gel-nsa-01-capsule-cannasencbd-arthritis-gel-cannasencbd-arth-supplement/ 2022-07-13T09:19:11+00:00 https://www.cs-medica.com/cs-medica-expands-presence-on-amazon-launches-in-germany/ 2022-07-12T13:04:07+00:00 https://www.cs-medica.com/cs-medica-presents-ceo-letter-of-july-2022/ 2022-07-12T09:29:53+00:00 https://www.cs-medica.com/ceo-lone-henriksen-buys-shares-in-the-company-2/ 2022-07-07T13:45:03+00:00 https://www.cs-medica.com/cs-medica-has-signed-a-distributor-agreement-with-slovenia-based-naturamedica/ 2022-06-28T07:50:40+00:00 https://www.cs-medica.com/cs-medica-has-signed-a-distributor-agreement-with-forbe-healthcare-ltd-corresponding-to-an-order-value-of-dkk-371-millions-over-a-35-year-period/ 2022-06-28T07:32:57+00:00 https://www.cs-medica.com/ceo-lone-henriksen-buys-shares-in-the-company/ 2022-06-22T15:25:28+00:00 https://www.cs-medica.com/cs-medica-presents-ceo-letter-of-june-2022/ 2022-06-10T12:58:14+00:00 https://www.cs-medica.com/life-science-investor-konference-1-juni-2022-praesenteret-af-okonomisk-ugebrev/ 2022-06-05T09:38:54+00:00 https://www.cs-medica.com/cfo-gitte-lund-henriksen-buys-more-shares-in-the-company-2/ 2022-06-03T11:56:42+00:00 https://www.cs-medica.com/cs-medica-a-s-secures-6-mdkk-in-loan-financing-to-maintain-momentum/ 2022-05-31T11:13:23+00:00 https://www.cs-medica.com/cs-medica-follow-up-on-their-participation-in-the-innovation-tours-2022-at-the-vitafoods-europe-2022/ 2022-05-20T15:22:54+00:00 https://www.cs-medica.com/cfo-gitte-lund-henriksen-buys-more-shares-in-the-company/ 2022-05-20T15:16:58+00:00 https://www.cs-medica.com/publication-of-half-year-report-for-the-financial-year-2021-2022/ 2022-05-20T14:41:08+00:00 https://www.cs-medica.com/cs-medica-signs-distributor-agreement-with-alsitan-order-value-44-mdkk/ 2022-05-11T08:23:17+00:00 https://www.cs-medica.com/cs-medica-presents-ceo-letter-of-may-2022/ 2022-05-03T17:44:57+00:00 https://www.cs-medica.com/cs-medica-has-signed-a-distributor-agreement-with-chinese-based-cbf-scitech-ltd-worth-dkk-1344-million-over-3-years/ 2022-04-29T12:12:00+00:00 https://www.cs-medica.com/cs-medica-announces-additional-product-availability-on-apopros-webshop-and-on-shelves-at-matas-186-medicare-stores/ 2022-04-27T14:40:16+00:00 https://www.cs-medica.com/cs-medica-has-been-approved-by-hong-kong-custom-and-has-received-a-trial-order-for-the-hong-kong-market/ 2022-04-22T09:40:34+00:00 https://www.cs-medica.com/cs-medica-provides-patent-update/ 2022-04-19T13:02:47+00:00 https://www.cs-medica.com/cs-medica-has-finalized-thc-test-at-ppb-level-on-their-cannasencbd-products-to-comply-with-the-strict-regulations-on-the-asian-market/ 2022-04-13T07:00:20+00:00 https://www.cs-medica.com/cs-medica-introduces-monthly-letter-from-the-ceo/ 2022-04-08T09:10:43+00:00 https://www.cs-medica.com/cs-medica-a-s-appoints-new-cgo-cmo/ 2022-04-08T08:33:00+00:00 https://www.cs-medica.com/cs-medica-announce-additional-product-availability-on-matas-webshop/ 2022-03-22T14:13:59+00:00 https://www.cs-medica.com/cs-medica-donates-products-to-charitable-organization-bevar-ukraine/ 2022-03-14T15:24:21+00:00 https://www.cs-medica.com/direct-issue-with-diaz-capital-invest-ab-finalized-at-8-50-dkk/ 2022-02-21T16:40:54+00:00 https://www.cs-medica.com/publication-of-interim-report-q1-2021-2022/ 2022-02-18T10:19:16+00:00 https://www.cs-medica.com/pfizers-announced-purchase-of-arena-pharmaceuticals-exemplifies-a-satisfactory-acquisition-within-the-cbd-medical-treatment-industry/ 2022-02-15T16:42:45+00:00 https://www.cs-medica.com/wp-content/uploads/2022/02/full-comparison-arena-pfizer_link.png https://www.cs-medica.com/notice-of-extraordinary-general-meeting-tuesday-february-3-2022/ 2022-02-04T18:31:10+00:00 https://www.cs-medica.com/statement-of-extraordinary-general-meeting/ 2022-02-04T11:25:34+00:00 https://www.cs-medica.com/cs-medica-a-s-signs-partnership-with-ampilio-in-preparation-of-amazon-expansion/ 2022-02-03T13:53:36+00:00 https://www.cs-medica.com/chairman-of-the-board-buys-shares-in-cs-medica/ 2022-01-26T12:08:21+00:00 https://www.cs-medica.com/cs-medica-recruits-4-new-employees-to-strengthen-the-sales-department/ 2022-01-06T14:06:06+00:00 https://www.cs-medica.com/cs-medica-a-s-sees-great-value-in-germanys-proposed-legislation-of-cannabis/ 2022-01-04T14:49:29+00:00 https://www.cs-medica.com/notice-of-shareholders-annual-meeting/ 2021-12-09T16:28:15+00:00 https://www.cs-medica.com/danish-parliament-voted-yes-for-a-permanent-scheme-for-medical-cannabis-in-denmark/ 2021-12-03T15:40:20+00:00 https://www.cs-medica.com/cs-medica-updates-regarding-market-territory/ 2021-12-03T15:35:19+00:00 https://www.cs-medica.com/notice-of-shareholders-annual-meeting-december-9-2021/ 2021-11-25T10:40:27+00:00 https://www.cs-medica.com/publication-of-annual-report/ 2021-11-25T10:21:44+00:00 https://www.cs-medica.com/cannordic-enters-a-reseller-agreement-for-cannasencbd-product-portfolio-with-directsalud-in-spain/ 2021-11-06T16:15:30+00:00 https://www.cs-medica.com/cs-medica-announce-extended-product-availability-together-with-kronan-apotek-in-sweden/ 2021-10-05T11:51:23+00:00 https://www.cs-medica.com/first-day-of-trading-in-cs-medica/ 2021-09-15T11:16:28+00:00